Clinical Trial

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus

Study acronym: ABCD
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This multicenter, double-blinded, randomized controlled trial aims to evaluate the effect of berberine on preventing cardiovascular disease and diabetes mellitus among individuals with high cardiometabolic risk in China.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-20; most recent amendment 2025-12-25.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-25
Trial Details
NCT Number NCT05749874
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions PreDiabetes, Abdominal Obesity, Hypertension, Dyslipidemias, Atherosclerotic Cardiovascular Disease
Enrollment 2,024 participants
Start Date 2023-10-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-31